Vanina Popova

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

Vanina Popova, Ella Daly, Madhukar H. Trivedi et al. · American Journal of Psychiatry · 2019 · 872 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Long-Term Safety and Maintenance of Response With Esketamine Nasal Spray in Participants With Treatment-Resistant Depression: Interim Results of the SUSTAIN-3 Study

Naim Zaki, Li Chen, Rosanne Lane et al. · Neuropsychopharmacology · 2023 · 120 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant

Stacie Hudgens, Lysbeth Floden, Michael Blackowicz et al. · Journal of Affective Disorders · 2020 · 76 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials

Ziad S. Saad, Derrek P. Hibar, Maggie Fedgchin et al. · The International Journal of Neuropsychopharmacology · 2020 · 43 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study

Mark E. Schmidt, Iva Kezic, Vanina Popova et al. · Neuropsychopharmacology · 2024 · 43 citations · Full text

Medicine, Pharmacology, Psychiatry +16